Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2023 Jul 31;14(7):485. doi: 10.1038/s41419-023-05939-1

Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

Chengjie Lin 1,2,3,#, Ting Li 4,#, Yan Wang 1,2,3, Shihui Lai 1,2,3, Yue Huang 1,2,3, Zhenyun Guo 1,2,3, Xiang Zhang 1,2,3,, Shangeng Weng 1,2,3,
PMCID: PMC10390565  PMID: 37524717

Correction to: Cell Death and Disease 10.1038/s41419-023-05715-1, published online 28 March 2023

In this article the funding note has been given erroneously:

This study was supported by grants: (I) Youth Scientific Reseach Project of Fujian Province Health Commission (2020QNA05*2*);

But should be read:

This study was supported by grants: (I) Youth Scientific Reseach Project of Fujian Province Health Commission (2020QNA05*1*);

The original article has been corrected.

Contributor Information

Xiang Zhang, Email: seva1101@163.com.

Shangeng Weng, Email: Shangeng@sina.com.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES